Spots Global Cancer Trial Database for hypercalcemia of malignancy
Every month we try and update this database with for hypercalcemia of malignancy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | NCT00301886 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | ibandronate zoledronate quality-of-life... | 18 Years - | SWOG Cancer Research Network | |
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer | NCT00326820 | Breast Cancer Hypercalcemia o... Metastatic Canc... | ibandronate sod... zoledronic acid Zolendronic Aci... | 18 Years - | Wales Cancer Trials Unit | |
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | NCT00060138 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | monoclonal anti... zoledronic acid | 18 Years - | Chugai Pharmaceutical | |
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone | NCT00458796 | Breast Cancer Hypercalcemia o... Metastatic Canc... Musculoskeletal... Pain | zoledronic acid quality-of-life... | 18 Years - 120 Years | University of Leeds | |
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | NCT00060138 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | monoclonal anti... zoledronic acid | 18 Years - | Chugai Pharmaceutical | |
One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | NCT00301886 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | ibandronate zoledronate quality-of-life... | 18 Years - | SWOG Cancer Research Network | |
A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM | NCT04198480 | Hypercalcemia o... | JMT103 | 18 Years - | Shanghai JMT-Bio Inc. | |
One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone | NCT00003884 | Hypercalcemia o... Lung Cancer Metastatic Canc... Pain Unspecified Adu... | zoledronic acid quality-of-life... | 18 Years - | Novartis | |
A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM | NCT04198480 | Hypercalcemia o... | JMT103 | 18 Years - | Shanghai JMT-Bio Inc. | |
Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | NCT00060138 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | monoclonal anti... zoledronic acid | 18 Years - | Chugai Pharmaceutical | |
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | NCT00896454 | Breast Cancer Hypercalcemia o... Colon Cancer Endocrine Cance... Head and Neck C... Kidney Cancer Lung Cancer Lymphoma Metastatic Canc... Multiple Myelom... Parathyroid Neo... Renal Cancer Thyroid Cancer Hodgkin's Lymph... Non-Hodgkin's L... Non-Small Cell ... | denosumab | 18 Years - | Amgen |